Skip to main content
. 2020 Nov 18;25(22):5398. doi: 10.3390/molecules25225398

Table 1.

Problems concerning the efficacy limitations of PDT for BCC treatment.

Problem Consequences and Details Sections
Clearance Surgery often preferred, though inferior cosmesis.
Not approved in some countries, including USA.
Section 3; Section 7.1.2.
Section 3.
Subtypes Restricted to nonaggressive, low-risk BCC. Section 3.
Penetration Even low-risk subtypes limited to thin (≤2mm) lesions.
Penetration of prodrug and light decrease with lesion depth.
Section 3.
Section 5.1.
PpIX accumulation Need increased PpIX at deeper levels where penetration is lower.
Adjuvant studies to increase PpIX accumulation.
Iron chelators to reduce conversion of PpIX to heme.
Differentiation promoters to improve PpIX accumulation.
Section 8.3.
Section 8.3.
Section 8.4.3.
Section 8.4.3.

PDT, photodynamic therapy; BCC, basal cell carcinoma; and PpIX, protoporphyrin IX.